Mainz Biomed N.V. (QUCY)Healthcare | Diagnostics & Research | Mainz, Germany | NasdaqCM
0.49 USD
-0.02
(-3.450%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.50 +0.01 (2.608%) ⇧ (April 17, 2026, 7:20 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:15 p.m. EDT
QUCY (Mainz Biomed N.V.) shows a highly volatile and declining price trend in the short term, with a current price of $0.443 that is significantly below its 52-week low of $0.40. The recent price history indicates a lack of consistent momentum, with the stock experiencing a downward spiral over the last 14 days. The short-term forecasting model predicts a further decline of approximately 16%, which suggests a negative outlook for short-term traders. The stock's fundamentals are also weak, with negative earnings, a high debt-to-equity ratio, and poor return metrics. Additionally, there are no dividend payouts in the recent history, making it unsuitable for dividend-focused investors. The long-term outlook is equally bleak, as the stock's fundamentals are not strong enough to support long-term growth. Overall, this stock is not recommended for either short-term or long-term investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.359068 |
| MSTL | 0.448142 |
| AutoARIMA | 0.454091 |
| AutoETS | 0.454096 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 12.44 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.211 |
| Excess Kurtosis | -1.24 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 400.798 |
| Revenue per Share | 0.09 |
| Market Cap | 6,094,968 |
| Beta | 0.47 |
| Previous Name | Mainz Biomed B.V. |
| Website | https://mainzbiomed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8413681 |
| Address1 | Robert Koch Strasse 50 |
| All Time High | 30.0 |
| All Time Low | 0.18 |
| Ask | 0.4998 |
| Ask Size | 3 |
| Average Daily Volume10 Day | 1,315,330 |
| Average Daily Volume3 Month | 717,629 |
| Average Volume | 717,629 |
| Average Volume10Days | 1,315,330 |
| Beta | 0.469 |
| Bid | 0.4668 |
| Bid Size | 3 |
| Book Value | 0.066 |
| City | Mainz |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Germany |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.487 |
| Current Ratio | 0.499 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.5194 |
| Day Low | 0.436 |
| Debt To Equity | 400.798 |
| Display Name | Mainz Biomed |
| Ebitda | -12,883,098 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.604 |
| Enterprise To Revenue | 14.481 |
| Enterprise Value | 7,777,396 |
| Eps Trailing Twelve Months | -2.7 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.64628 |
| Fifty Day Average Change | -0.15928 |
| Fifty Day Average Change Percent | -0.24645665 |
| Fifty Two Week Change Percent | -84.13681 |
| Fifty Two Week High | 4.43 |
| Fifty Two Week High Change | -3.9429998 |
| Fifty Two Week High Change Percent | -0.8900677 |
| Fifty Two Week Low | 0.4 |
| Fifty Two Week Low Change | 0.08699998 |
| Fifty Two Week Low Change Percent | 0.21749996 |
| Fifty Two Week Range | 0.4 - 4.43 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,636,119,000,000 |
| Float Shares | 10,848,043 |
| Free Cashflow | -7,107,252 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.72576 |
| Gross Profits | 389,792 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15561 |
| Held Percent Institutions | 0.0945 |
| Implied Shares Outstanding | 12,515,336 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany. |
| Long Name | Mainz Biomed N.V. |
| Market | us_market |
| Market Cap | 6,094,968 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1679642292 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -16,210,718 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 6,094,968 |
| Open | 0.5095 |
| Operating Cashflow | -10,979,587 |
| Operating Margins | -21.5986 |
| Payout Ratio | 0.0 |
| Phone | 49 6131 554 2860 |
| Post Market Change | 0.012700021 |
| Post Market Change Percent | 2.6078074 |
| Post Market Price | 0.4997 |
| Post Market Time | 1,776,468,025 |
| Prev Name | Mainz Biomed B.V. |
| Previous Close | 0.5044 |
| Price Hint | 4 |
| Price To Book | 7.3787875 |
| Price To Sales Trailing12 Months | 11.348343 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.271 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0174 |
| Regular Market Change Percent | -3.44965 |
| Regular Market Day High | 0.5194 |
| Regular Market Day Low | 0.436 |
| Regular Market Day Range | 0.436 - 0.5194 |
| Regular Market Open | 0.5095 |
| Regular Market Previous Close | 0.5044 |
| Regular Market Price | 0.487 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 677,716 |
| Return On Assets | -0.89615 |
| Return On Equity | -4.88316 |
| Revenue Growth | -0.329 |
| Revenue Per Share | 0.09 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 12,515,336 |
| Shares Percent Shares Out | 0.022 |
| Shares Short | 275,109 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 467,577 |
| Short Name | Mainz Biomed N.V. |
| Short Percent Of Float | 0.024400001 |
| Short Ratio | 0.46 |
| Source Interval | 15 |
| Symbol | QUCY |
| Total Cash | 889,091 |
| Total Cash Per Share | 0.071 |
| Total Debt | 2,571,519 |
| Total Revenue | 537,080 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.7 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.25105 |
| Two Hundred Day Average Change | -0.76405 |
| Two Hundred Day Average Change Percent | -0.610727 |
| Type Disp | Equity |
| Volume | 677,716 |
| Website | https://mainzbiomed.com |
| Zip | 55,129 |